期刊文献+

遗传因素对高血压患者血压正常子女左心结构及舒张功能的影响

Genetic influence on left ventricular structure and diastolic function in normotensive offspring of parents with essential hypertension
下载PDF
导出
摘要 目的:利用超声心动图技术探讨遗传因素对有高血压家族史的血压正常者左室结构及舒张功能的影响。方法:血压正常者100例,其中无高血压家族史者50例(对照组),有高血压家族史者50例(试验组)。分别行M型、二维超声及多普勒组织成像(DTI)检测左心形态及舒张功能,比较两组间的差异。结果:试验组舒张末期室间隔厚度(IVST)及舒张末期左室后壁厚度(LVPWT)、左室质量指数(LVMI)均高于对照组。二尖瓣环舒张早期运动速度e及e与二尖瓣环舒张晚期运动速度a比值(e/a)较对照组减低,差异有显著性(P<0.05);两组之间主动脉根部内径(AOD)、左心室舒张末期内径(LVIDed)、左房内径(LA)及二尖瓣口舒张早期血流速度峰值E、左房收缩期血流速度峰值A、E/A无显著差异。结论:易患高血压的高危人群其心脏形态及功能的变化可先于血压升高而发生,遗传因素对其发生有一定的影响。 Objectives: To compare the difference of the left ventricular mass and diastolic function in normotensive offspring with or without a familial history of hypertension. Methods: 100 normotensive offspring with ages ranging from 15 to 40 years old were assessed, 50 had hypertensive parents (NOH) and 50 had normotensive parents (NON). By echocardiography and doppler tissue imaging, the following parameters of left ventricular structure and diastolic function were examined: IVST, LVPWT, LVIDed, LVMI, e/a and E/A ratio. Results: Compared with NON, the normotensive offspring of hypertensive parents had greater IVST,LVPWT and LVMI, lower peak velocity of the early diastolic wave(e) of mitral annulus, and lower c/a ratio (P〈0. 05). No differences in LVIDed,LA,AOD and E/A ratio were found between the two groups. Conculsion: The results indicate that genetic factor of parental hypertension influences left ventricular structure and diastolic function in normotensive offspring, suggesting that cardiac involvement may precede the elevation of blood pressure.
出处 《国际心血管病杂志》 2006年第1期60-62,共3页 International Journal of Cardiovascular Disease
关键词 遗传因素 血压正常子女 左室质量指数 舒张功能 多普勒组织成像 Genetic factor Normotensive offspring Left ventricular mass Diastolic function Doppler tissue imaging
  • 相关文献

参考文献7

二级参考文献27

  • 1Devereux RB, Koren MJ, de Simone G, et al. Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease. Eur Heart J ,1993, 14 Suppl D:8-15.
  • 2Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.J Clin Invest, 1990 , 86:1343-1346.
  • 3Kupari M, Hautanen A, Lankinen L, et al. Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. Circulation, 1998,97:569-575.
  • 4Brand E, Chatelain N, Mulatero P, et al. Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension, 1998,32:198-204.
  • 5Tamaki S,Iwai N,Tsujita Y, et al. Genetic polymorphism of CYP11B2 gene and hypertension in Japanese. Hypertension, 1999, 33:266-270.
  • 6Hautanen A, Toivanen P, Manttari M,et al. Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction.Circulation, 1999,100:2213-2218.
  • 7Tsujita Y, Iwai N, Katsuya T, et al. Lack of association between genetic polymorphism of CYP11B2 and hypertension in Japanese: the Suita Study. Hypertens Res, 2001, 24:105-109.
  • 8White PC, Hautanen A, Kupari M. Aldosterone synthase (CYP11B2) polymorphisms and cardiovascular function. J Steroid Biochem Mol Biol, 1999,69:409-412.
  • 9Young M, Fullerton M, Dilley R, et al. Mineralocorticoids, hypertension, and cardiac fibrosis. J Clin Invest, 1994, 93:2578-2583.
  • 10Fuentes RM, Natkola IL, Shemeikka S, et al. J Hum Hypertens, 2000; 14(7): 441-445

共引文献119

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部